专利检索 ap:("GW Pharma Limited" OR "Otsuka Pharmaceutical Co., Limited") AND inv:"Ben Whalley" 第 1 页

1.

发明授权
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy 有权

公开(公告)号：US10799467B2

公开(公告)日：2020-10-13

申请号：US14685753

申请日：2015-04-14

申请人： GW Pharma Limited , Otsuka Pharmaceutical Co., Limited

发明人： Ben Whalley , Claire Williams , Gary Stephens , Takashi Futamura

IPC分类号： A61K31/05 , A61K31/515 , A61K31/19 , A61K31/352 , A61K31/40 , A61K36/185 , A61K45/06

摘要： This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.

2.

发明申请
USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY 审中-公开
标题翻译：利多卡因胆碱（CBDV）在治疗急性胰腺炎中的应用

公开(公告)号：US20150320698A1

公开(公告)日：2015-11-12

申请号：US14685753

申请日：2015-04-14

申请人： GW Pharma Limited , Otsuka Pharmaceutical Co., Limited

发明人： Ben Whalley , Claire Williams , Gary Stephens , Takashi Futamura

IPC分类号： A61K31/05 , A61K31/515 , A61K31/19 , A61K45/06

摘要： This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.

摘要翻译： 本发明涉及植物大麻素大麻素（CBDV）和植物大麻素CBDV与四氢大麻素（THCV）和大麻二醇（CBD）的组合在治疗癫痫中的用途。本发明还涉及植物大麻素CBDV与标准抗癫痫药（SAED）的组合的用途。优选地，SAED是乙酰亚胺，丙戊酸盐或苯巴比妥之一。

3.

发明授权
Use of the phytocannabinoid cannabidivarin (CBDV) in the treatment of epilepsy 有权

公开(公告)号：US12023305B2

公开(公告)日：2024-07-02

申请号：US17012448

申请日：2020-09-04

申请人： GW Pharma Limited

发明人： Ben Whalley , Claire Williams , Gary Stephens , Takashi Futamura

IPC分类号： A61K31/05 , A61K31/19 , A61K31/352 , A61K31/40 , A61K31/515 , A61K36/185 , A61K45/06 , A61P25/08

CPC分类号： A61K31/05 , A61K31/19 , A61K31/352 , A61K31/40 , A61K31/515 , A61K36/185 , A61K45/06 , A61P25/08 , A61K31/05 , A61K2300/00 , A61K31/19 , A61K2300/00 , A61K31/352 , A61K2300/00 , A61K31/40 , A61K2300/00

摘要： This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.